Table 3.
Antibiotic sensitivity pattern of Gram-negative microorganisms (n = 83)
| Antibiotic |
Klebsiella spp n (%) |
E. coli n (%) |
Proteus spp n (%) |
Enterobacter spp n (%) |
Pseudomonas spp n (%) |
Acinetobacter spp n (%) |
Anaerobes* n (%) |
|---|---|---|---|---|---|---|---|
| Ampicillin | 0 (0) | 2 (40) | 8 (57) | 1 (17) | - | - | - |
| Gentamicin | 11 (100) | 5 (100) | 12 (86) | 8 (100) | - | 0 (0) | - |
| Amikacin | 11 (100) | 5 (100) | 14 (100) | 8 (100) | - | 0 (0) | - |
| Cefuroxime | 8 (73) | 3 (60) | 12 (86) | 8 (100) | - | - | - |
| Cefotaxime | 8 (73) | 3 (60) | 14 (100) | 8 (100) | - | 0 (0) | - |
| Ceftazidime | 8 (73) | 3 (60) | 14 (100) | 8 (100) | 36 (97) | 0 (0) | - |
| Cefepime | 8 (73) | 3 (60) | 14 (100) | 8 (100) | 35 (95) | 0 (0) | - |
| Amoxycillin-clavulanate | 8 (73) | 5 (100) | 7 (50) | 2 (33) | - | - | - |
| Trimethoprim sulfamethoxazole | 8 (73) | 5 (100) | 12 (86) | 4 (67) | - | 0 (0) | - |
| Ciprofloxacin | 10 (91) | 5 (100) | 13 (93) | 8 (100) | 34 (92) | 0 (0) | - |
| Piperacillin-tazobactam | 11 (100) | 5 (100) | 14 (100) | 8 (100) | 34 (92) | 0 (0) | - |
| Ertapenem | 11 (100) | 5 (100) | 14 (100) | 8 (100) | - | - | - |
| Meropenem | 11 (100) | 5 (100) | 14 (100) | 8 (100) | 36 (97) | 0 (0) | - |
| Imipenem | 11 (100) | 5 (100) | 13 (93) | 8 (100) | 37 (100) | 0 (0) | - |
| Metronidazole | - | - | - | - | - | - | 2 (100) |
| Polymyxin b | - | - | - | - | - | 6 (100) | - |
| Colistin | - | - | - | - | - | 6 (100) | - |
*
Bacteroides fragilis